|
Balance Sheet Cash Flow Statement 301 Penobscot Dr. Redwood City, CA 94063 CA Tel. 650-556-9300 Fax 650-556-1132 |
Type: Public
On the web:
http://www.genomichealth.com
Employees:
387
Employee growth: 34.4%
Genomic Health believes the genome is key to good health. The company conducts genomic research to develop molecular diagnostics and assays that can predict the likelihood of disease recurrence and response to therapy and treatments. Genomic Health's Onco"type" DX assay predicts the likelihood of chemotherapy effectiveness and breast cancer recurrence in women with newly diagnosed, early stage invasive breast cancer. The company markets its products to oncologists and pathologists. Genomic Health's research efforts are targeted at providing a wider base of cancer-related tests.
Key numbers for fiscal year ending December, 2008:
Sales: $110.6M
One year growth: 72.7%
Net income: ($16.1)M
Officers:
Chairman: Randal W. (Randy) Scott
President, CEO, and Director: Kimberly J. (Kim) Popovits
COO, CFO, and Secretary: G. Bradley (Brad) Cole
Competitors:
Clarient
Genzyme
Life Technologies Corporation
